Pamela Genovese, PA

Pamela Genovese practices at Great South Bay Endoscopy in East Patchogue, New York.

Pamela Genovese's NPI, 1639544158, was assigned on December 9, 2015. Pamela Genovese holds New York license 016593.

Pamela Genovese's primary practice is Great South Bay Endoscopy, at 260 Patchogue Yaphank Road, East Patchogue, NY 11772. The practice phone is (631) 289-2716.

Pamela Genovese's primary practice is Great South Bay Endoscopy in East Patchogue, New York. Pamela Genovese is also affiliated with NYU Langone Hospital-Suffolk. The medical group on file is Brookhaven Gastroenterology Associates. Dmand AI also links Pamela Genovese to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Pamela Genovese practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Pamela Genovese's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Pamela Genovese is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). Pamela Genovese is licensed in New York.

Dmand AI lists acute gastroduodenitis and gastroenteritis among the conditions Pamela Genovese treats.

CMS data shows 416 Medicare services from Pamela Genovese across 2 procedure codes in 2024, all of them office visits, for 274 Medicare patients. Medicare paid $28,471 for them. Every service was in an office.

CMS counts 274 Medicare patients who saw Pamela Genovese in 2024. The largest group is 65 to 74, with 136 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.37, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Pamela Genovese's median patient age at 65, with 56% women.

In 2024, Pamela Genovese wrote 870 Medicare Part D claims for 306 patients. 84% of them were for generic drugs. CMS names the drug for 765 of them, across 14 drugs with 11 or more claims each, at $103,772 in total drug cost.

Pamela Genovese accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 122 general payments to Pamela Genovese from 15 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $646.